Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zerubavel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature|December 23, 1976
Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reactionJ E Byfield, R Zerubavel, E W Fonkalsrud
Surgery|August 1, 1978
Morphological evaluation of canine autogeneous vein grafts in the arterial circulationE W Fonkalsrud, M Sanchez, R Zerubavel
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. I. In vitro and in vivo treatment using normal, gamma-irradiated and immune-stimulated rat effector cellsJ E Byfield, R Zerubavel, E W Fonkalsrud
Journal of Autoimmunity|October 1, 1992
Autoimmune thyroiditis (EAT) in genetically resistant mice mediated by a T cell lineR Zerubavel-Weiss, D Markovits, I R Cohen
Surgery, Gynecology & Obstetrics|September 1, 1977
Serial changes in arterial structure following radiation therapyE W Fonkalsrud, M Sanchez, R Zerubavel, et al.
Surgery|May 1, 1977
Serial changes in arterial endothelium following ischemia and perfusionE W Fonkalsrud, M Sanchez, R Zerubavel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. II. In vitro and in vivo treatment using effector cells from normal and X-irradiated humansJ E Byfield, R Zerubavel, E W Fonkalsrud
Immunogenetics|January 1, 1983
Molecular events in the processing of avidin by antigen-presenting cells (APC). III. Activation of T-lymphocyte lines and H-2 restriction are mediated by processed avidin associated with I-region gene productsA Friedman, R Zerubavel, C Gitler, et al.
Immunogenetics|January 1, 1983
Molecular events in the processing of avidin by antigen-presenting cells (APC). II. Identical processing by APC of H-2 high- and low-responder mouse strainsA Friedman, R Zerubavel, C Gitler, et al.
Surgical Forum|January 1, 1976
Correlation of endothelial damage with fibrinogen 125I accumulation in arteriesM Sanchez, R Zerubavel, M Webber, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature|December 23, 1976
Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reactionJ E Byfield, R Zerubavel, E W Fonkalsrud
Surgery|August 1, 1978
Morphological evaluation of canine autogeneous vein grafts in the arterial circulationE W Fonkalsrud, M Sanchez, R Zerubavel
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. I. In vitro and in vivo treatment using normal, gamma-irradiated and immune-stimulated rat effector cellsJ E Byfield, R Zerubavel, E W Fonkalsrud
Journal of Autoimmunity|October 1, 1992
Autoimmune thyroiditis (EAT) in genetically resistant mice mediated by a T cell lineR Zerubavel-Weiss, D Markovits, I R Cohen
Surgery, Gynecology & Obstetrics|September 1, 1977
Serial changes in arterial structure following radiation therapyE W Fonkalsrud, M Sanchez, R Zerubavel, et al.
Surgery|May 1, 1977
Serial changes in arterial endothelium following ischemia and perfusionE W Fonkalsrud, M Sanchez, R Zerubavel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. II. In vitro and in vivo treatment using effector cells from normal and X-irradiated humansJ E Byfield, R Zerubavel, E W Fonkalsrud
Immunogenetics|January 1, 1983
Molecular events in the processing of avidin by antigen-presenting cells (APC). III. Activation of T-lymphocyte lines and H-2 restriction are mediated by processed avidin associated with I-region gene productsA Friedman, R Zerubavel, C Gitler, et al.
Immunogenetics|January 1, 1983
Molecular events in the processing of avidin by antigen-presenting cells (APC). II. Identical processing by APC of H-2 high- and low-responder mouse strainsA Friedman, R Zerubavel, C Gitler, et al.
Surgical Forum|January 1, 1976
Correlation of endothelial damage with fibrinogen 125I accumulation in arteriesM Sanchez, R Zerubavel, M Webber, et al.
Pageof 2